insights_auto
Why is INO down 2,05%?
Dive Deeperchevron_right
INO:NASDAQ
Inovio Pharmaceuticals Inc
1,43 $
arrow_downward
-2,05%(-0,030) 1D
1,43 $
0,00% (0,00)
bedtimeAfter hours
Closed: 13 նոյ, 16:00:01 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for INO...
Open
1,44 $
High
1,48 $
Low
1,39 $
Mkt. cap
267,85 մլն
Avg. vol.
19,26 մլն
Volume
5,22 մլն
52-wk high
2,72 $
52-wk low
0,56 $
EPS
-0,80 $
Beta
1,71
Shares outstanding
187,31 մլն
No. of employees
112
Open
1,44 $
High
1,48 $
Low
1,39 $
Mkt. cap
267,85 մլն
Avg. vol.
19,26 մլն
Volume
5,22 մլն
52-wk high
2,72 $
52-wk low
0,56 $
EPS
-0,80 $
Beta
1,71
Shares outstanding
187,31 մլն
No. of employees
112
News stories
From web sources and news partners
News Corp
·
7 ժամ առաջ
Inovio Pharmaceuticals Inc. stock underperforms Friday when compared to competitors
Seeking Alpha
·
12 ժամ առաջ
Inovio Pharmaceuticals, Inc. 2026 Q3 - Results - Earnings Call Presentation (NASDAQ:INO) 2026-11-13
Profile
Inovio Pharmaceuticals, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases. In April 2020, Inovio was among some 100 companies, academic centers, or research organizations developing a vaccine candidate for treating people infected with COVID-19, with more than 170 total vaccine candidates in development. Wikipedia
About Inovio Pharmaceuticals Inc